Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR
- PMID: 14638868
Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR
Abstract
The role of the protein kinase B (PKB/Akt) in the regulation of cell survival and proliferation is well established. PKB is a key effector in the phosphatidylinositol 3-kinase pathway and plays a role in the initiation of S phase and in the G(2)-M transition. I report here that activated PKB shortens the G(2) arrest induced by DNA damage and promotes early entry into mitosis. Activated PKB supports high levels of expression and activity of the polo-like kinase 1 (Plk1) after DNA damage as cells accumulate in G(2). The checkpoint protein CHFR implicated in degradation of Plk1 is involved in the regulation of Plk1 by PKB. PKB phosphorylates CHFR in vitro and in vivo. Expression of a mutant form of CHFR that cannot be phosphorylated by PKB results in reduction of levels of Plk1 and inhibition of mitotic entry under normal conditions and after DNA damage. Results of this study support a model in which PKB facilitates mitotic resolution of DNA damage-induced G(2) arrest by inhibiting the checkpoint function of CHFR. The deregulated activation of PKB that occurs frequently in tumors might inhibit CHFR activity after DNA damage and therefore promote Plk1 accumulation leading to the disruption of the DNA damage checkpoint.
Similar articles
-
Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.Mol Cancer Res. 2004 Jul;2(7):417-26. Mol Cancer Res. 2004. PMID: 15280449
-
The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.J Cell Biol. 2002 Jan 21;156(2):249-59. doi: 10.1083/jcb.200108016. Epub 2002 Jan 21. J Cell Biol. 2002. PMID: 11807090 Free PMC article.
-
Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.Cell Cycle. 2005 Jan;4(1):166-71. doi: 10.4161/cc.4.1.1348. Epub 2005 Jan 5. Cell Cycle. 2005. PMID: 15611664
-
Getting in and out of mitosis with Polo-like kinase-1.Oncogene. 2005 Apr 18;24(17):2844-59. doi: 10.1038/sj.onc.1208617. Oncogene. 2005. PMID: 15838519 Review.
-
Polo-like kinase 1 reaches beyond mitosis--cytokinesis, DNA damage response, and development.Curr Opin Cell Biol. 2008 Dec;20(6):650-60. doi: 10.1016/j.ceb.2008.10.005. Epub 2008 Nov 27. Curr Opin Cell Biol. 2008. PMID: 19000759 Review.
Cited by
-
Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice.J Clin Invest. 2009 Sep;119(9):2714-24. doi: 10.1172/JCI37405. Epub 2009 Aug 17. J Clin Invest. 2009. PMID: 19690386 Free PMC article.
-
Dma1 ubiquitinates the SIN scaffold, Sid4, to impede the mitotic localization of Plo1 kinase.EMBO J. 2011 Jan 19;30(2):341-54. doi: 10.1038/emboj.2010.317. Epub 2010 Dec 3. EMBO J. 2011. PMID: 21131906 Free PMC article.
-
The auto-ubiquitylation of E3 ubiquitin-protein ligase Chfr at G2 phase is required for accumulation of polo-like kinase 1 and mitotic entry in mammalian cells.J Biol Chem. 2011 Sep 2;286(35):30615-30623. doi: 10.1074/jbc.M111.231803. Epub 2011 Jul 15. J Biol Chem. 2011. PMID: 21768102 Free PMC article.
-
Physiological and oncogenic Aurora-A pathway.Int J Biol Sci. 2009 Nov 26;5(7):758-62. doi: 10.7150/ijbs.5.758. Int J Biol Sci. 2009. PMID: 20011137 Free PMC article. Review.
-
Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.Cancer. 2010 Sep 1;116(17):4033-42. doi: 10.1002/cncr.25151. Cancer. 2010. PMID: 20564104 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Miscellaneous